Cardinal Health, Inc. (CAH) News
Track canonical SquawkNews coverage tagged to CAH, Cardinal Health, Inc.. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 11 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
CAH: Double-digit growth across all segments, robust specialty gains, and strong cash flow progress
All five segments delivered strong double-digit earnings growth, with specialty and pharma outperforming expectations. Strategic acquisitions and operational improvements are driving sustainable growth, while contract st
EARNINGS | Sep 15, 2026, 02:34 PM UTC
H
CAH: Strong segment growth, robust cash flow, and strategic M&A drive continued performance
All five segments posted strong earnings growth, with specialty and M&A as key drivers, though future growth is expected to normalize. Strategic execution, stable customer renewals, and a focus on automation and targeted
EARNINGS | Sep 15, 2026, 01:59 PM UTC
H
CAH: Specialty and generics growth, strategic M&A, and disciplined investment drive strong outlook
Strong FY 2026 results were driven by specialty and generics, with FY 2027 guidance above long-term targets. Growth is supported by acquisitions, robust specialty and nuclear businesses, and disciplined capital allocatio
EARNINGS | Sep 09, 2026, 02:23 PM UTC
H
CAH sees FY 2027 EPS growth guidance of 13%-15%
CAH reported strong FY 2026 results tied to specialty and generics growth and guided FY 2027 EPS growth of 13%-15%. The company cited acquisition integration, cost management and targeted M&A.
EARNINGS | Sep 09, 2026, 01:43 PM UTC
M
Near 50dma resistance TIGO FICO LEN AFRM ESS DOC CXT FIS EXEL AN CNC CZR COST USB STZ BPOP BRKB CTVA ORCL DD TSLA PB MTB KR CL EWBC MCD AMG
Near 50dma resistance TIGO FICO LEN AFRM ESS DOC CXT FIS EXEL AN CNC CZR COST USB STZ BPOP BRKB CTVA ORCL DD TSLA PB MTB KR CL EWBC MCD AMG RF MLI PFG CASY OTIS FCN TPL CAH SFM SBAC NVR
EQUITY | Aug 21, 2026, 06:36 PM UTC
H
Cardinal Health gets RBC Buy, $276 target on Nuclear Medicine
RBC Capital Markets initiates Cardinal Health with a buy rating and a $276 price target, citing the company’s Nuclear Medicine business and its expected profit contribution.
EARNINGS | Aug 19, 2026, 01:15 PM UTC
L
CAH initiated Outperform at RBC Capital with $276 target
RBC Capital initiates CAH with an Outperform rating and a $276.00 price target.
EQUITY | Aug 19, 2026, 11:55 AM UTC
H
S&P 500 Falls Ahead of Inflation Report
The S&P 500 falls for the second straight session amid a decline in tech stocks
EARNINGS | Aug 12, 2026, 06:57 AM UTC
H
Dow Falls Over 50 Points Ahead of Inflation Data: Fear Index Remains in ‘Greed’ Zone
The CNN Money Fear and Greed index showed no change in the overall market sentiment, while the index remained in the “Greed” zone on Monday. U.S. stocks settled mostly lower on Monday, with the Dow Jones index falling mo
EARNINGS | Aug 11, 2026, 07:44 AM UTC
H
Cardinal Health price target raised to $275 from $255 at TD Cowen
TD Cowen raised the firm's price target on Cardinal Health to $275 from $255 and keeps a Buy rating on the shares. The firm updated its model ahead of the upcoming earnings season and they see the company guiding FY27 ad
EQUITY | Jul 09, 2026, 12:50 PM UTC
L
B of A Securities Maintains Buy on Cardinal Health, Raises Price Target to $260
B of A Securities analyst Allen Lutz maintains Cardinal Health (NYSE: CAH ) with a Buy and raises the price target from $240 to $260.
EQUITY | Jul 02, 2026, 03:00 PM UTC